Patent(s) and the Corresponding Patented Drug(s) |
Top |
World Intellectual Property Organization (WIPO) |
Patent ID |
WO2012013418 |
Title |
Skin Care Compositions Comprising Substituted Monoamines. |
Abstract |
Skin care compositions comprising certain substituted phenethylamines, which are particularly beneficial for skin lightening and achieving evenness of color, especially for face and underarm skin. The compositions comprise 0.001% to 20% of a subtituted monoamine of structure (I) wherein R, is cyclohexyl, pheryl or mono - or di-substituted phenyl substituted by C1-C5 alkyl, C1-C5 alkoxy or phenoxy and R2 is hydrogen or methyl. |
Applicant(s) |
Hindustan Unilever Limited |
Representative Drug(s) |
D00EGV |
Drug Info
|
N.A. |
Click to Show More |
[1] |
2
|
D02TIY
|
Drug Info
|
N.A.
|
[1] |
3
|
D03KNZ
|
Drug Info
|
N.A.
|
[1] |
4
|
D0SD9L
|
Drug Info
|
N.A.
|
[1] |
5
|
D0X5VH
|
Drug Info
|
N.A.
|
[1] |
Patent ID |
WO2014004177 |
Title |
Topical Application of 1-Hydroxyl 3,5-Bis(4'Hydroxyl Styryl)Benzene. |
Abstract |
The present invention relates to compositions 1-hydroxyl 3,5-bis(4'hydroxyl styryl)benzene or a cosmetically acceptable salt thereof, and methods of treating human skin using said compositions. |
Applicant(s) |
Johnson & Johnson Consumer Companies, Inc |
Representative Drug(s) |
D0I3KT |
Drug Info
|
N.A. |
[1] |
Patent ID |
WO2012154959 |
Title |
Peptide Tyrosinase Inhibitors and Uses Thereof. |
Abstract |
Disclosed are peptides that inhibit the enzymatic activity of tyrosinase, as well as formulations and methods for their use in the reduction of skin pigmentation, and methods of administering the inhibitory pep tides in a topical formulation. Prefened octapeptide sequences are internally rich in tryptophan and/or tyrosine or arginine. The present invention is further directed to kits and compositions containing the present peptides, and methods of treatment of conditions involving expression of tyrosinase, in which the present peptides are administered topically for the treatment of conditions involving melanocyte activity in the skin. |
Applicant(s) |
Elixir Institute of Regenerative Medicine |
Patent ID |
WO2009003034 |
Title |
Oligopeptide Tyrosinase Inhibitors and Uses Thereof. |
Abstract |
Disclosed are peptides that inhibit the enzymatic activity of tyrosinase, as well as formulations and methods for their use in the reduction of skin pigmentation, and methods of administering the inhibitory peptides in a topical formulation. Peptide sequences disclosed include KFEKKFEK and YRSRKYSSWY. |
Applicant(s) |
The Board of Trustes of the Leland Stanford Junior University |
Patent ID |
WO2013073763 |
Title |
Heterocyclic Resorcinol Derivatives, Preparation of Same and Cosmetic Uses Thereof. |
United States Patent and Trademark Office (USPTO) |
Patent ID |
US8119674 |
Title |
4-Phenylimidazole-2-Thione Tyrosinase Inhibitors and Pharmaceutical/Cosmetic Applications Thereof. |
Applicant(s) |
Galderma Research & Development |
Representative Drug(s) |
D06KKO |
Drug Info
|
IC50 = 300 nM |
Click to Show More |
[1] |
2
|
D0A0RM
|
Drug Info
|
IC50 = 400 nM
|
[1] |
3
|
D0PN6U
|
Drug Info
|
IC50 = 1400 nM
|
[1] |
Patent ID |
US7989483 |
Title |
4-Heteroarylimidazole-2-Thione Tyrosinase Inhibitors and Pharmaceutical/Cosmetic Applications Thereof. |
Applicant(s) |
Galderma Research & Development |
Representative Drug(s) |
D0X0RV |
Drug Info
|
IC50 = 100 nM |
Click to Show More |
[1] |
2
|
D02SGL
|
Drug Info
|
IC50 = 200 nM
|
[1] |
3
|
D0M4EQ
|
Drug Info
|
IC50 = 300 nM
|
[1] |
Patent ID |
US20140234241 |
Title |
Novel Benzoic Acid Amide Compound. |
Representative Drug(s) |
D0MM1Y |
Drug Info
|
IC50 = 800 nM |
Click to Show More |
[1] |
2
|
D01RTO
|
Drug Info
|
IC50 = 900 nM
|
[1] |
3
|
D0D2JW
|
Drug Info
|
IC50 = 900 nM
|
[1] |
4
|
D09YKI
|
Drug Info
|
IC50 = 1100 nM
|
[1] |
5
|
D0GW5H
|
Drug Info
|
IC50 = 1400 nM
|
[1] |
Patent ID |
US20130129646 |
Title |
Cyclohexyl Carbamate Compounds As Skin and/or Hair Lightening Actives. |
Representative Drug(s) |
D0F3HA |
Drug Info
|
IC50 = 4700 nM |
Click to Show More |
[1] |
2
|
D0J2HH
|
Drug Info
|
IC50 = 4700 nM
|
[1] |
3
|
D03PYA
|
Drug Info
|
IC50 = 5500 nM
|
[1] |
4
|
D0L1SV
|
Drug Info
|
IC50 = 5600 nM
|
[1] |
5
|
D0UT9H
|
Drug Info
|
IC50 = 9500 nM
|
[1] |
6
|
D09VRO
|
Drug Info
|
IC50 = 10000 nM
|
[1] |
7
|
D0LC2G
|
Drug Info
|
IC50 = 94100 nM
|
[1] |
8
|
D06LIQ
|
Drug Info
|
IC50 = 219400 nM
|
[1] |
Patent ID |
US8362305 |
Title |
Series of Skin Whitening (Lightening) Compounds. |
Representative Drug(s) |
D0TL2C |
Drug Info
|
IC50 = 165 nM |
Click to Show More |
[1] |
2
|
D0JC3U
|
Drug Info
|
IC50 = 200 nM
|
[1] |
3
|
D0PI1Z
|
Drug Info
|
IC50 = 250 nM
|
[1] |
4
|
D0P6ZB
|
Drug Info
|
IC50 = 350 nM
|
[1] |
5
|
D0X7EQ
|
Drug Info
|
IC50 = 500 nM
|
[1] |
6
|
D0ZJ4M
|
Drug Info
|
IC50 = 500 nM
|
[1] |
7
|
D03MKE
|
Drug Info
|
IC50 = 800 nM
|
[1] |
8
|
D0NR2A
|
Drug Info
|
IC50 = 850 nM
|
[1] |
9
|
D0CH3F
|
Drug Info
|
IC50 = 860 nM
|
[1] |
10
|
D05NHA
|
Drug Info
|
IC50 = 1000 nM
|
[1] |
11
|
D04ZZM
|
Drug Info
|
IC50 = 1020 nM
|
[1] |
12
|
D02JVX
|
Drug Info
|
IC50 = 1800 nM
|
[1] |
13
|
D06WGO
|
Drug Info
|
IC50 = 2000 nM
|
[1] |
14
|
D0RC7R
|
Drug Info
|
IC50 = 3000 nM
|
[1] |
15
|
D06YKN
|
Drug Info
|
IC50 = 5150 nM
|
[1] |
16
|
D01EVP
|
Drug Info
|
IC50 = 8400 nM
|
[1] |
17
|
D0EQ3V
|
Drug Info
|
IC50 = 12800 nM
|
[1] |
18
|
D0E6LU
|
Drug Info
|
IC50 = 50000 nM
|
[1] |
19
|
D0KU5J
|
Drug Info
|
IC50 = 60000 nM
|
[1] |
20
|
D09QZB
|
Drug Info
|
N.A.
|
[1] |
21
|
D0FL1E
|
Drug Info
|
N.A.
|
[1] |
22
|
D0K7LI
|
Drug Info
|
N.A.
|
[1] |
23
|
D0T7BH
|
Drug Info
|
N.A.
|
[1] |
Patent ID |
US20140363388 |
Title |
Series of Skin Whitening (Lightening) Compounds. |
Representative Drug(s) |
D0TL2C |
Drug Info
|
IC50 = 165 nM |
Click to Show More |
[1] |
2
|
D0JC3U
|
Drug Info
|
IC50 = 200 nM
|
[1] |
3
|
D0PI1Z
|
Drug Info
|
IC50 = 250 nM
|
[1] |
4
|
D0P6ZB
|
Drug Info
|
IC50 = 350 nM
|
[1] |
5
|
D0X7EQ
|
Drug Info
|
IC50 = 500 nM
|
[1] |
6
|
D0ZJ4M
|
Drug Info
|
IC50 = 500 nM
|
[1] |
7
|
D03MKE
|
Drug Info
|
IC50 = 800 nM
|
[1] |
8
|
D0NR2A
|
Drug Info
|
IC50 = 850 nM
|
[1] |
9
|
D0CH3F
|
Drug Info
|
IC50 = 860 nM
|
[1] |
10
|
D05NHA
|
Drug Info
|
IC50 = 1000 nM
|
[1] |
11
|
D04ZZM
|
Drug Info
|
IC50 = 1020 nM
|
[1] |
12
|
D02JVX
|
Drug Info
|
IC50 = 1800 nM
|
[1] |
13
|
D06WGO
|
Drug Info
|
IC50 = 2000 nM
|
[1] |
14
|
D0RC7R
|
Drug Info
|
IC50 = 3000 nM
|
[1] |
15
|
D06YKN
|
Drug Info
|
IC50 = 5150 nM
|
[1] |
16
|
D01EVP
|
Drug Info
|
IC50 = 8400 nM
|
[1] |
17
|
D0EQ3V
|
Drug Info
|
IC50 = 12800 nM
|
[1] |
18
|
D0E6LU
|
Drug Info
|
IC50 = 50000 nM
|
[1] |
19
|
D0KU5J
|
Drug Info
|
IC50 = 60000 nM
|
[1] |
20
|
D09QZB
|
Drug Info
|
N.A.
|
[1] |
21
|
D0FL1E
|
Drug Info
|
N.A.
|
[1] |
22
|
D0K7LI
|
Drug Info
|
N.A.
|
[1] |
23
|
D0T7BH
|
Drug Info
|
N.A.
|
[1] |
Patent ID |
US8889881 |
Title |
Novel Compound Having Skin-Whitening, Anti-Oxidizing and Ppar Activities and Medical Use Therefor. |
Representative Drug(s) |
D00DYI |
Drug Info
|
N.A. |
Click to Show More |
[1] |
2
|
D00JQA
|
Drug Info
|
N.A.
|
[1] |
3
|
D01CFL
|
Drug Info
|
N.A.
|
[1] |
4
|
D03PLQ
|
Drug Info
|
N.A.
|
[1] |
5
|
D0AE8D
|
Drug Info
|
N.A.
|
[1] |
6
|
D0HH4L
|
Drug Info
|
N.A.
|
[1] |
7
|
D0IB3Z
|
Drug Info
|
N.A.
|
[1] |
8
|
D0J6DS
|
Drug Info
|
N.A.
|
[1] |
9
|
D0MT3J
|
Drug Info
|
N.A.
|
[1] |
10
|
D0WT1C
|
Drug Info
|
N.A.
|
[1] |
11
|
D0YX1C
|
Drug Info
|
N.A.
|
[1] |
12
|
D0Z0DX
|
Drug Info
|
N.A.
|
[1] |
Patent ID |
US8846012 |
Title |
Melanin Production Inhibitor. |
Representative Drug(s) |
D00LSQ |
Drug Info
|
N.A. |
Click to Show More |
[1] |
2
|
D02CXZ
|
Drug Info
|
N.A.
|
[1] |
3
|
D02WJB
|
Drug Info
|
N.A.
|
[1] |
4
|
D0A2RI
|
Drug Info
|
N.A.
|
[1] |
5
|
D0K2XK
|
Drug Info
|
N.A.
|
[1] |
6
|
D0KR9E
|
Drug Info
|
N.A.
|
[1] |
7
|
D0U5GU
|
Drug Info
|
N.A.
|
[1] |
Patent ID |
US8476251 |
Title |
Skin Care Compositions Comprising Substituted Diamines. |
Representative Drug(s) |
D01QYA |
Drug Info
|
N.A. |
Click to Show More |
[1] |
2
|
D0L0CV
|
Drug Info
|
N.A.
|
[1] |
3
|
D0QU3G
|
Drug Info
|
N.A.
|
[1] |
Patent ID |
US8435548 |
Title |
Peptide Derivatives and Cosmetic Composition Comprising The Same. |
Representative Drug(s) |
D08OJB |
Drug Info
|
N.A. |
Click to Show More |
[1] |
2
|
D0AG7M
|
Drug Info
|
N.A.
|
[1] |
3
|
D0CI2U
|
Drug Info
|
N.A.
|
[1] |
4
|
D0F0VF
|
Drug Info
|
N.A.
|
[1] |
5
|
D0QC9I
|
Drug Info
|
N.A.
|
[1] |
6
|
D0X4EC
|
Drug Info
|
N.A.
|
[1] |
Patent ID |
US8425885 |
Title |
Substituted 3-(Phenoxymethyl) Benzyl Amines and Personal Care Compositions. |
Representative Drug(s) |
D0CP6B |
Drug Info
|
N.A. |
Click to Show More |
[1] |
2
|
D0MA7A
|
Drug Info
|
N.A.
|
[1] |
3
|
D0Q1NF
|
Drug Info
|
N.A.
|
[1] |
4
|
D0VY9O
|
Drug Info
|
N.A.
|
[1] |
5
|
D0XO4I
|
Drug Info
|
N.A.
|
[1] |
6
|
D0Z1LJ
|
Drug Info
|
N.A.
|
[1] |
Patent ID |
US20150164758 |
Title |
Tyrosinase Inhibitors. |
Representative Drug(s) |
D07UBZ |
Drug Info
|
N.A. |
Click to Show More |
[1] |
2
|
D0H4LK
|
Drug Info
|
N.A.
|
[1] |
Patent ID |
US20150017111 |
Title |
Compound Having Skin-Whitening, Anti-Oxidizing and Ppar Activities and Medical Use Therefor. |
Representative Drug(s) |
D00DYI |
Drug Info
|
N.A. |
Click to Show More |
[1] |
2
|
D00JQA
|
Drug Info
|
N.A.
|
[1] |
3
|
D01CFL
|
Drug Info
|
N.A.
|
[1] |
4
|
D03PLQ
|
Drug Info
|
N.A.
|
[1] |
5
|
D0AE8D
|
Drug Info
|
N.A.
|
[1] |
6
|
D0HH4L
|
Drug Info
|
N.A.
|
[1] |
7
|
D0IB3Z
|
Drug Info
|
N.A.
|
[1] |
8
|
D0J6DS
|
Drug Info
|
N.A.
|
[1] |
9
|
D0MT3J
|
Drug Info
|
N.A.
|
[1] |
10
|
D0WT1C
|
Drug Info
|
N.A.
|
[1] |
11
|
D0YX1C
|
Drug Info
|
N.A.
|
[1] |
12
|
D0Z0DX
|
Drug Info
|
N.A.
|
[1] |
Patent ID |
US20150010484 |
Title |
Method for Anti-Skin Aging Using Caffeamide Derivative. |
Representative Drug(s) |
D07RUH |
Drug Info
|
N.A. |
Click to Show More |
[1] |
2
|
D09EFW
|
Drug Info
|
N.A.
|
[1] |
Patent ID |
US20140256830 |
Title |
Resorcinol Compounds for Dermatological Use. |
Representative Drug(s) |
D00QVY |
Drug Info
|
N.A. |
Click to Show More |
[1] |
2
|
D07PSJ
|
Drug Info
|
N.A.
|
[1] |
3
|
D07RJD
|
Drug Info
|
N.A.
|
[1] |
4
|
D0G5CV
|
Drug Info
|
N.A.
|
[1] |
5
|
D0H0UC
|
Drug Info
|
N.A.
|
[1] |
6
|
D0IH6G
|
Drug Info
|
N.A.
|
[1] |
7
|
D0K1UO
|
Drug Info
|
N.A.
|
[1] |
8
|
D0K6TN
|
Drug Info
|
N.A.
|
[1] |
9
|
D0Q1HU
|
Drug Info
|
N.A.
|
[1] |
10
|
D0QR0E
|
Drug Info
|
N.A.
|
[1] |
11
|
D0ZT3U
|
Drug Info
|
N.A.
|
[1] |
Patent ID |
US20140023603 |
Title |
Novel Compound Having Skin-Whitening, Anti-Oxidizing and Ppar Activities and Medical Use Therefor. |
Representative Drug(s) |
D03NCL |
Drug Info
|
N.A. |
Click to Show More |
[1] |
2
|
D03PZZ
|
Drug Info
|
N.A.
|
[1] |
3
|
D09JLP
|
Drug Info
|
N.A.
|
[1] |
4
|
D09MHU
|
Drug Info
|
N.A.
|
[1] |
5
|
D0A8UJ
|
Drug Info
|
N.A.
|
[1] |
6
|
D0G7XW
|
Drug Info
|
N.A.
|
[1] |
7
|
D0HO0I
|
Drug Info
|
N.A.
|
[1] |
8
|
D0J0BB
|
Drug Info
|
N.A.
|
[1] |
9
|
D0JR0P
|
Drug Info
|
N.A.
|
[1] |
10
|
D0K5JG
|
Drug Info
|
N.A.
|
[1] |
11
|
D0N7BW
|
Drug Info
|
N.A.
|
[1] |
12
|
D0SJ1U
|
Drug Info
|
N.A.
|
[1] |
Patent ID |
US20130272983 |
Title |
Para-Coumaric Acid or Para-Hydroxycinnamic Acid Derivatives and Their Use In Cosmetic or Dermatological Compositions. |
Representative Drug(s) |
D01VTT |
Drug Info
|
N.A. |
Click to Show More |
[1] |
2
|
D06LMS
|
Drug Info
|
N.A.
|
[1] |
3
|
D0J4YH
|
Drug Info
|
N.A.
|
[1] |
4
|
D0O3JR
|
Drug Info
|
N.A.
|
[1] |
5
|
D0SF6C
|
Drug Info
|
N.A.
|
[1] |
6
|
D0SJ4S
|
Drug Info
|
N.A.
|
[1] |
Patent ID |
US20110039898 |
Title |
Method for Scavenging Free Radicals and Inhibiting Tyrosinase and Melanin. |
Representative Drug(s) |
D03FQY |
Drug Info
|
N.A. |
Click to Show More |
[1] |
2
|
D0FQ3D
|
Drug Info
|
N.A.
|
[1] |
Patent ID |
US20120323012 |
Title |
4-(Azacycloalkyl)-Benzene-1, 3-Diol Derivatives As Tyrosinase Inhibitors and Their Synthesis and Use Thereof. |
Representative Drug(s) |
D04HEW |
Drug Info
|
IC50 = 200 nM |
[1] |
Patent ID |
US20130266526 |
Title |
Dihydroxyfumaric Acid Derivatives and The Use Thereof for Skin Lightening. |
Representative Drug(s) |
D0LA2R |
Drug Info
|
N.A. |
[1] |
Patent ID |
US8822428 |
Title |
Double-Stranded Rna Oligonucleotides Which Inhibit Tyrosinase Expression. |
Patent ID |
US8193154 |
Title |
Oligopeptide Tyrosinase Inhibitors and Uses Thereof. |
Patent ID |
US8026208 |
Title |
Peptide Tyrosinase Inhibitors and Uses Thereof. |
Patent ID |
US6132740 |
Title |
Resorcinol Derivatives. |
Patent ID |
US5399785 |
Title |
Tyrosinase Activity Inhibitor. |
Patent ID |
US5026686 |
Title |
Antiviral Peptides. |
Patent ID |
US4959393 |
Title |
Skin Depigmental Agent. |
Patent ID |
US20140112878 |
Title |
ATyrosinase Inhibitor. |
Patent ID |
US20130164233 |
Title |
Skin-Whitening Essence Composition Containing Tyrosinase Inhibitor. |
Patent ID |
US20120321577 |
Title |
Skin-Whitening Composition Containing Tyrosinase Inhibitor. |
Patent ID |
US20080131382 |
Title |
Skin Lightening Agents, Compositions and Methods. |
European Patent Office (EPO) |
Patent ID |
EP2529735 |
Title |
4-(Heterocycloalkyl) Benzene-1, 3-Diol Compounds As Tyrosinase Inhibitors, Process for The Preparation Thereof and Use Thereof In Human Medicine and Also In Cosmetics. |
Representative Drug(s) |
D0W6ZO |
Drug Info
|
IC50 = 100 nM |
Click to Show More |
[1] |
2
|
D01NJW
|
Drug Info
|
IC50 = 400 nM
|
[1] |
Patent ID |
EP2746253 |
Title |
Novel Compounds with Skin Lightening Properties. |
Representative Drug(s) |
D02EGY |
Drug Info
|
N.A. |
Click to Show More |
[1] |
2
|
D03BRP
|
Drug Info
|
N.A.
|
[1] |
3
|
D05XAH
|
Drug Info
|
N.A.
|
[1] |
4
|
D07DFC
|
Drug Info
|
N.A.
|
[1] |
5
|
D0P0PT
|
Drug Info
|
N.A.
|
[1] |
6
|
D0UT0X
|
Drug Info
|
N.A.
|
[1] |
Patent ID |
EP2295403 |
Title |
Compound with Carboxyl Acid Group and Amide Group and Application Thereof. |
Representative Drug(s) |
D00YRS |
Drug Info
|
N.A. |
Click to Show More |
[1] |
2
|
D01ZCC
|
Drug Info
|
N.A.
|
[1] |
3
|
D06FUM
|
Drug Info
|
N.A.
|
[1] |
4
|
D07PNX
|
Drug Info
|
N.A.
|
[1] |
5
|
D0EH4P
|
Drug Info
|
N.A.
|
[1] |
6
|
D0W8RV
|
Drug Info
|
N.A.
|
[1] |
Patent ID |
EP0341664 |
Title |
Skin Depigmental Agent. |
China National Intellectual Property Administration (CNIPA) |
Patent ID |
CN103371924 |
Title |
ATyrosinase Retardant. |
Canadian Intellectual Property Office (CIPO) |
Patent ID |
CA2835755 |
Title |
Family of Aryl, Heteroaryl, O-Aryl and O-Heteroaryl Carbasugars. |
Representative Drug(s) |
D0DW3Z |
Drug Info
|
IC50 = 328 nM |
[1] |